Lessons from Alzheimer's Disease (AD) Clinical Trials: Instead of “A-Drug”, AD-D prevention to Avert AD

Simple item page
dc.contributor.authorLahiri, Debomoy K.
dc.contributor.departmentPsychiatry, School of Medicineen_US
dc.date.accessioned2020-07-02T19:07:31Z
dc.date.available2020-07-02T19:07:31Z
dc.date.issued2019
dc.eprint.versionAuthor's manuscripten_US
dc.identifier.citationLahiri, D. K. (2019). Lessons from Alzheimer’s Disease (AD) Clinical Trials: Instead of “A-Drug”, AD-D prevention to Avert AD. Current Alzheimer Research, 16(4), 279–280. https://doi.org/10.2174/156720501604190424114752en_US
dc.identifier.urihttps://hdl.handle.net/1805/23167
dc.language.isoenen_US
dc.publisherBenthamen_US
dc.relation.isversionof10.2174/156720501604190424114752en_US
dc.relation.journalCurrent Alzheimer Researchen_US
dc.rightsPublisher Policyen_US
dc.sourceAuthoren_US
dc.subjectAlzheimer’s diseaseen_US
dc.subjectclinical trialsen_US
dc.subjectpreventive medicineen_US
dc.titleLessons from Alzheimer's Disease (AD) Clinical Trials: Instead of “A-Drug”, AD-D prevention to Avert ADen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Lahiri2019Lessons.pdf
Size:
209.18 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Open Access Policy Articles
Department of Psychiatry Works